title: Antiplatelet therapy in percutaneous coronary intervention: is variability of response clinically relevant?
authors.affiliation: Wessex Cardiothoracic Unit, Southampton University Hospital, Southampton, UK. nick.curzen@suht.swest.nhs.uk
authors.forename: Nick
authors.initials: N
authors.lastname: Curzen
authors.forename: Nalyaka
authors.initials: N
authors.lastname: Sambu
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D003131:Combined Modality Therapy; D003328:Coronary Thrombosis / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin